Feb 2018

FIRST TASMANIANS APPROVED UNDER NEW SCHEME TO USE MEDICINAL CANNABIS

In an attempt to stem the seizures in her son Joe, Kaye Dick just started treating her son with medically prescribed cannabis. Joe has suffered severe epilepsy since he was two. Joe is one of the first approved to access medically prescribed cannabis under the State Government’s controlled access scheme.

Wendy Latimer who also suffers from seizures has also been approved to receive the treatment. The 57-year-old suffers one large seizure a day, and about 100 smaller ones. Her family commented that Wendy’s been on almost every medication that is possible and that medical marijuana is probably the last resort to provide her with relief.

Both Joe and Wendy will be monitored by scientists to collect data into the effect of medicinal cannabis.

Read the article here.

 

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

What’s most important in business – purpose or profit? At ANTG we get to achieve both.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >